Jeffrey Cadeddu, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Transenterix
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Titan Medical, Inc
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Levita Magnetics
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Monarch Bioimplants
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Onconano
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Transenterix
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Titan Medical, Inc
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Levita Magnetics
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Monarch Bioimplants
    Date added:
    Date updated:
    11/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Onconano
    Date added:
    Date updated:
    11/30/2023

Pages

Return to Update Series (2020) Lesson 38: Ablative Therapies for Renal Masses: Current Treatment Indications, Types and Outcomes